GSK is investing £45 m with the Fleming Initiative to launch six “Grand Challenge” research programmes using cutting-edge AI to tackle antimicrobial resistance against pathogens like MRSA, Gram-negative bacteria, and fungi.
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.
Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.
